EcoDrugPlus

Ensembl ID : ENSCVAG00000015942
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSCVAG00000008452
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSCVAG00000008286
Gene Symbol: -
Cross references: -
252 Possible Orthologues:

Ensembl ID : ENSCVAG00000008244
Gene Symbol: -
Cross references: -
252 Possible Orthologues:

Ensembl ID : ENSCVAG00000008029
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSCVAG00000007047
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSCVAG00000018566
Gene Symbol: -
Cross references: -
266 Possible Orthologues:

Ensembl ID : ENSCVAG00000016021
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSCVAG00000005374
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSCVAG00000017144
Gene Symbol: -
Cross references: -
167 Possible Orthologues:

Ensembl ID : ENSCVAG00000010111
Gene Symbol: -
Cross references: -
363 Possible Orthologues:

Ensembl ID : ENSCVAG00000006227
Gene Symbol: -
Cross references: -
216 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).